Remes J, Tikkanen I, Fyhrquist F, Pyörälä K
Kuopio University, Central Hospital, Finland.
Br Heart J. 1991 May;65(5):249-55. doi: 10.1136/hrt.65.5.249.
Neuroendocrine activity was studied in 60 consecutive untreated patients with dyspnoea and a clinical suspicion of heart failure. On the basis of the so-called Boston clinical criteria the diagnosis of heart failure was regarded as unlikely in 26 patients, possible in 15 patients, and definite in 19 patients. These groups were studied before any drug treatment was started and were compared with a control group of 69 healthy individuals. Plasma atrial natriuretic peptide concentration was clearly raised in patients with definite heart failure and slightly raised in patients with possible heart failure. Plasma adrenaline concentration was somewhat raised in patients with definite or possible heart failure, whereas plasma noradrenaline concentration was raised only in patients with definite heart failure. Plasma renin activity was not increased in any of the patient groups and plasma aldosterone concentration was slightly increased only in patients with definite heart failure. In the total patient series there were significant correlations between plasma atrial natriuretic peptide concentration and markers of the severity of left ventricular dysfunction. There was some evidence of neuroendocrine activation in untreated heart failure: plasma concentrations of atrial natriuretic peptide and catecholamines were increased but the renin-angiotensin-aldosterone system showed little or no activation.
对60例连续的未经治疗的呼吸困难且临床怀疑心力衰竭的患者进行了神经内分泌活性研究。根据所谓的波士顿临床标准,26例患者被认为心力衰竭诊断不太可能,15例患者可能患有心力衰竭,19例患者确诊为心力衰竭。在开始任何药物治疗之前对这些组进行了研究,并与69名健康个体的对照组进行了比较。确诊心力衰竭的患者血浆心钠素浓度明显升高,可能患有心力衰竭的患者血浆心钠素浓度略有升高。确诊或可能患有心力衰竭的患者血浆肾上腺素浓度有所升高,而仅确诊心力衰竭的患者血浆去甲肾上腺素浓度升高。任何患者组的血浆肾素活性均未增加,仅确诊心力衰竭的患者血浆醛固酮浓度略有增加。在整个患者系列中,血浆心钠素浓度与左心室功能障碍严重程度标志物之间存在显著相关性。在未经治疗的心力衰竭中存在一些神经内分泌激活的证据:血浆心钠素和儿茶酚胺浓度升高,但肾素-血管紧张素-醛固酮系统几乎没有或没有激活。